Sign Up | Log In | What is SocialPicks?

Free Stock Picks by Top Performers

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Aircarp

Start Tracking Aircarp - Add to Friends - Send Message

Community Rank: Sr. Analyst (460 pts) | Member since 03/31/2007

Picks Performance:

Outperforms

61%

of community

What's this?

All-time Return +52.88% (in over 5 years)	Risk (SD) Aggressive 0.00%	Sharpe Ratio -9.67
Followers 3	Winning Picks 11 of 19	Total Views 19431

Overview

Stocks

Stats

Community

Widget

Shared Picks | Personal Portfolio | Voted Picks | Commented On

View: Shared Picks (Quick) / (Detailed) | Personal Portfolio

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
CAMH	N/A	04/20/10	n/a	+0.00%	n/a	CAMH cleared for takeoff!	1
MGRM		06/18/07	n/a	-13.93%	-86.07%	Medi-Cal Expands Coverage Of Baseline HIV..	6
PCYC		05/31/07	+964.82%	-13.90%	+978.72%	PCYC CEO confident of approval	1
DNDN		05/31/07	-13.29%	-13.90%	+0.61%	Stage set for approval next year	7
NGNM	N/A	04/20/07	n/a	-11.22%	-88.78%	New growth opportunity in medical laborat..	6

Open | Closed

Symbol	SP Sentiment	Date	Return	Market	v.s. Market	Title	Pts
CAMH	N/A	04/13/07	n/a	-9.29%	-90.71%	CAMH breaks through $3.30 resistance	8
MGRM		05/03/07	+3.95%	-12.29%	+16.24%	Monogram licenses patent portfolio to Cal..	37
CFC		05/31/07	+3.14%	-13.90%	-10.77%	CFC setting up to retrace some of its gai..	1
PWRM	N/A	04/19/07	-13.04%	-10.40%	-2.65%	Power3 Medical Receives CLIA High-Complex..	6
CFC		04/10/07	+14.31%	-9.01%	+23.32%	Out-of-favor sector about to release thei..	12
DORB	N/A	04/13/07	-70.15%	-9.29%	-60.86%	DOR BioPharma rejects buyout offer	6
DNDN		05/09/07	+21.61%	-12.88%	+8.73%	Dendreon receives the dreaded approvable ..	6
MGRM		04/25/07	-8.76%	-11.88%	+3.11%	Monogram Biosciences Expectations Too Hig..	22
JAVO	N/A	04/12/07	+8.33%	-8.98%	+17.31%	A fresh approach to the specialty drink m..	6
PCYC		04/23/07	+1.52%	-11.01%	-9.49%	FDA files NDA for Pharmacyclics drug Xcyt..	6
NNLX	N/A	04/13/07	-16.67%	-9.29%	-7.37%	Reiterate Buy on NNLX	1
NPHC	N/A	04/13/07	+0.00%	-9.29%	+9.29%	Patent filed for a method of treating Aut..	6
DNDN		04/16/07	+0.64%	-10.25%	-9.61%	Dendreon's sell off not over	7
MGRM		04/23/07	-13.78%	-11.01%	-2.76%	Monogram Biosciences in Play	12
PCYC		04/04/07	+19.27%	-8.44%	+27.72%	Pharmacyclics Challenges FDA	37
CTIC		04/13/07	-1.94%	-9.29%	+7.36%	Cell Therapeutics Inc rebounds after offe..	6
PWRM	N/A	04/13/07	+0.00%	-9.29%	+9.29%	Power3 Medical upgrades Patent Applicatio..	6
CAB		04/13/07	-0.99%	-9.29%	+8.31%	Bullish on CAB ...	0
CAMH	N/A	04/11/07	n/a	-8.41%	n/a	Stock back on it's upward trend and ready..	13
DNDN		04/11/07	+17.47%	-8.41%	+9.06%	Dendreon Downgraded	6

« previous
1
2
next »

Similarity to Me ?

Compare Your Portfolio With Aircarp: Enter stocks you like & get new ideas daily:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Aircarp

Avg exp holding time:
287.94 days

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.